Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
I-Hung Shih, PhD
MANAGING DIRECTOR AND CO-HEAD, BIOTECH PRIVATE INVESTMENTS, WELLINGTON MANAGEMENT
Should I stay (Private) or should I go (Public)?
Placeholder Photo
Hirokazu Shimoda, ACA
DIRECTOR, BIO-INDUSTRY DIVISION, COMMERCE AND SERVICE INDUSTRY POLICY GROUP, MINISTRY OF ECONOMY, TRADE AND INDUSTRY（JAPAN）
Japan
Tokyo, Japan
Hee-Young Shin, LLM
HEAD OF GLOBAL BUSINESS TEAM, BASGENBIO INC.
Basgenbio Inc.
Seoul, Republic of Korea
Nick Shipley
CHIEF ADVOCACY OFFICER, BIO
A Price Control Odyssey : The Inflation Reduction Act’s Effects on the Innovation Ecosystem
The Inflation Reduction Act - A Market-Driven Event Impacting the Development of New Treatments
Brian Silver, JD
CFO, TSCAN THERAPEUTICS
Beyond Equity: Extreme Innovation in Financing for Public Biotechs
Peter Silverstone
CEO & DIRECTOR, ZYLORION HEALTH
Psychedelics… the Trip Continues
Calgary, Alberta, Canada
Lauren Silvis
SENIOR VICE PRESIDENT OF EXTERNAL AFFAIRS, TEMPUS
In Vitro Diagnostics Regulation in the US and Beyond: Trends and Strategies to Navigate Change
Amy Simon, MD
CHIEF MEDICAL OFFICER, BEAM THERAPEUTICS
The Next Generation of Gene Editing Therapeutic Technologies
Placeholder Photo
Camilla Simpson
CEO, ZEHNA THERAPEUTICS INC
Zehna Therapeutics Inc
Ruchita Sinha
GENERAL PARTNER, AV8 VENTURES
Meeting Patients' Needs Through Innovative Digital Tools